Physician

Ramakrishna Chakilam, M.D

According to 2025 Medicare claims, Ramakrishna Chakilam, M.D (NPI: 1649438193) practices pulmonary disease in the Corpus Christi, TX market, with the plurality of this provider's patient population coming from Nueces, TX. This provider's primary affiliated billing organization is TEXAS COASTAL BEND PULMONARY & CRITICAL CARE ASSOCIATES PLLC (NPI: 1497270680; TIN: 822315152) and primary practice location at 78414-4208.

Chakilam's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,040 traditional Medicare patients, billed 6,764 HCPCS/CPT codes, and received $488,205 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 12,260 prescription claims across 1,260 beneficiaries totaling $4,430,138 in drug costs, led by Ofev (Nintedanib Esylate). DME data shows 2,980 claims. Open Payments data shows 51 records totaling $5,667. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $84,868 to $488,205. Similarly, Part D prescription costs have moved sharply higher in recent years, from $66,091 to $4,430,138. For DME billing, reported payments rose steadily, from $20,174 to $273,532.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	265	1,182	$84,868
2016	655	3,318	$251,469
2017	668	3,228	$257,648
2018	778	4,307	$335,143
2019	982	5,045	$360,916
2020	1,035	5,668	$397,335
2021	923	5,082	$353,718
2022	961	5,486	$388,009
2023	1,000	6,202	$461,645
2024	1,040	6,764	$488,205

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	106	343	$66,091
2016	150	594	$116,345
2017	265	1,581	$420,340
2018	421	2,355	$744,585
2019	509	3,532	$1,513,187
2020	625	4,762	$1,910,741
2021	763	6,586	$2,931,050
2022	1,012	8,660	$4,330,283
2023	1,119	11,191	$4,352,363
2024	1,260	12,260	$4,430,138

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	29	232	$15,763
2016	126	583	$58,107
2017	199	965	$86,468
2018	354	1,395	$130,670
2019	482	2,297	$194,353
2020	501	2,074	$222,336
2021	524	2,210	$259,092
2022	706	2,689	$240,097
2023	871	2,982	$254,723
2024	929	2,980	$312,320

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	463	1,149	$93
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	461	3,146	$59
94729	Test to examine how well the lungs exchange gases	285	288	$41
94726	Test to determine lung volumes using sensors	299	302	$41
94060	Test to measure expiratory airflow and volume changes before and after medication administration	299	302	$28

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ofev	Nintedanib Esylate	100	3,180	$1,307,440
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	1,152	45,810	$966,997
Arikayce	Amikacin Liposomal/Neb.Accessr	32	896	$484,955
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	539	19,590	$409,658
Eliquis	Apixaban	197	6,742	$129,911

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	14	89	$92,821
E0483	High frequency chest wall oscillation system, with full anterior and/or posterior thoracic region receiving simultaneous external oscillation, includes all accessories and supplies, each	Y	N/R	45	$43,632
J7677	Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram	N	N/R	44	$34,812
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	45	308	$27,972
E0601	Continuous positive airway pressure (cpap) device	Y	62	344	$12,704

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	51	$5,667	INTUITIVE SURGICAL, INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ramakrishna Chakilam, M.D?

Tedicare shows public-source Medicare data for Ramakrishna Chakilam, M.D (NPI 1649438193), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ramakrishna Chakilam, M.D have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ramakrishna Chakilam, M.D?

Ramakrishna Chakilam, M.D is linked to TEXAS COASTAL BEND PULMONARY & CRITICAL CARE ASSOCIATES PLLC (billing NPI 1497270680) in the available physician profile data.

Does Ramakrishna Chakilam, M.D have Open Payments data?

Ramakrishna Chakilam, M.D has 51 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.